All articles
Inflammatory Bowel Disease
Lymphoma, inflammatory bowel disease and immunosuppression – (07-23-01)
James Bogash
Lymphoma, inflammatory bowel disease and immunosuppression
The idea of long term immunosupression to manage a chronic disease has always concerned me. This article reviews the concern, to include the use of the new TNF-alpha receptor blockage medications, of increase risk of lyphoma. Many, if not all, cases of inflammatory bowel disease can respond wonderfully to functional medicine concepts and lifestyle changes. The increased risk of cancer with these therapies that suppress the immune system is opposing Mother Nature, and the downstream effects of this are beyond our current knowledge.
Synergy : Alimentary Pharmacology & Therapeutics 15 (8), 1101-1108
